Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Efficacy and Safety Of Melphalan and Prednisone In Combination With Thalidomide, Bortezomib Or Lenalidomide In Newly Diagnosed Transplant-Ineligible Multiple Myeloma Patients: A Single Center Experience

Fabiana Gentilini, MD, Vincenzo Federico, MD, Eleonora Russo, MD, Paola Finsinger, MD, Roberto Ricci, Patrizia Del Bianco, Francesca Prestanicola, Moira Cappelloni, Maria Letizia Vallone, Robin Foa, MD, Maria Teresa Petrucci, MD

Blood (2013) 122 (21): 5375.

https://doi.org/10.1182/blood.V122.21.5375.5375

Published: 2013

Journal Articles

Type of Relapse in 91 Newly Diagnosed MM Patients Treated with High Dose Chemotherapy Followed by Autologous Stem Cell Transplantation.

Maria Teresa Petrucci, MD, Giuseppe Avvisati, MD, PhD, Ombretta Annibali, MD, Saveria Capria, MD, Maria S. De Propris, PhD, Patrizia Del Bianco, PhD, Vincenzo Federico, Cristiano Gallucci, MD, Maria Gozzer, MD, Chiara Gregorj, PhD, Annalisa Natale, MD, Azzurra Romeo, MD, Giovanna Meloni, MD, Robert Foa, MD

Blood (2006) 108 (11): 5451.

https://doi.org/10.1182/blood.V108.11.5451.5451

Published: 2006

Journal Articles

Velcade as Retreatment of Multiple Myeloma Patients Previously Responsive to Velcade.

Maria Teresa Petrucci, MD, Cristiano Gallucci, MD, Vincenzo Federico, Patrizia Del Bianco, PhD, Robert Foa, MD

Blood (2006) 108 (11): 5088.

https://doi.org/10.1182/blood.V108.11.5088.5088

Published: 2006

Journal Articles

Velcade an Active Agent for Multiple Myeloma Patients. Experience of a Single Center.

Maria Teresa Petrucci, MD, Vincenza Martini, MD, Cristiano Gallucci, MD, Erica Finolezzi, MD, Anna Levi, MD, Patrizia Del Bianco, PhD, Franco Mandelli, MD, Robert Foà, MD

Blood (2005) 106 (11): 5151.

https://doi.org/10.1182/blood.V106.11.5151.5151

Published: 2005

Journal Articles

Long Term Follow-Up of 198 IgM Monoclonal Gammopathy of Undetermined Significance (MGUS).

Ombretta Annibali, MD, Maria T. Petrucci, MD, Francesco Bartolozzi, MD, Anna Levi, MD, Patrizia Del Bianco, BSc, Cristiano Gallucci, MD, Robin Foa, MD, Franco Mandelli, MD, Giuseppe Avvisati, MD.PhD

Blood (2004) 104 (11): 4859.

https://doi.org/10.1182/blood.V104.11.4859.4859

Published: 2004

Journal Articles

Natural History of 656 Patients with Non IgM MGUS.

Carolina Nobile, MD, Maria T. Petrucci, MD, Francesco Bartolozzi, MD, Anna Levi, MD, Marianna De Muro, MD, Maria C. Tirindelli, MD, Patrizia Del Bianco, BSc, Cristiano Gallucci, MD, Franco Mandelli, MD, Giuseppe Avvisati, MD

Blood (2004) 104 (11): 4860.

https://doi.org/10.1182/blood.V104.11.4860.4860

Published: 2004

Journal Articles

Oral Melphalan, Cyclophosfamide and Prednisone (MCP) in 72 Newly Diagnosed Waldenström’s Macroglobulinemia Patients: Results and Costs Analysis.

Maria Teresa Petrucci, MD, Ombretta Annibali, MD, Anna Levi, MD, Maria C. Tirindelli, MD, Carolina Fossati, MD, Cristiano Gallucci, MD, Patrizia Del Bianco, BSc, Franco Mandelli, MD, Giuseppe Avvisati, MD, PhD

Blood (2004) 104 (11): 3298.

https://doi.org/10.1182/blood.V104.11.3298.3298

Published: 2004

NARROW

Efficacy and Safety Of Melphalan and Prednisone In Combination With Thalidomide, Bortezomib Or Lenalidomide In Newly Diagnosed Transplant-Ineligible Multiple Myeloma Patients: A Single Center Experience

Type of Relapse in 91 Newly Diagnosed MM Patients Treated with High Dose Chemotherapy Followed by Autologous Stem Cell Transplantation.

Velcade as Retreatment of Multiple Myeloma Patients Previously Responsive to Velcade.

Velcade an Active Agent for Multiple Myeloma Patients. Experience of a Single Center.

Long Term Follow-Up of 198 IgM Monoclonal Gammopathy of Undetermined Significance (MGUS).

Natural History of 656 Patients with Non IgM MGUS.

Oral Melphalan, Cyclophosfamide and Prednisone (MCP) in 72 Newly Diagnosed Waldenström’s Macroglobulinemia Patients: Results and Costs Analysis.

Email alerts

ASH Publications

American Society of Hematology

Efficacy and Safety Of Melphalan and Prednisone In Combination With Thalidomide, Bortezomib Or Lenalidomide In Newly Diagnosed Transplant-Ineligible Multiple Myeloma Patients: A Single Center Experience

Type of Relapse in 91 Newly Diagnosed MM Patients Treated with High Dose Chemotherapy Followed by Autologous Stem Cell Transplantation.

Velcade as Retreatment of Multiple Myeloma Patients Previously Responsive to Velcade.

Velcade an Active Agent for Multiple Myeloma Patients. Experience of a Single Center.

Long Term Follow-Up of 198 IgM Monoclonal Gammopathy of Undetermined Significance (MGUS).

Natural History of 656 Patients with Non IgM MGUS.

Oral Melphalan, Cyclophosfamide and Prednisone (MCP) in 72 Newly Diagnosed Waldenström’s Macroglobulinemia Patients: Results and Costs Analysis.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only